Sun Pharmaceutical Industries Ltd.

Daiichi Sankyo has reportedly started the sale of the Sun Pharmaceutical’s stake, worth up to $3.6 billion, through accelerated book building. Daiichi Sankyo is selling the said stake at price lower than market level.

After the sale, Daiichi Sankyo will not be a major shareholder of Sun Pharma. As of April 16, 2015, Daiichi owned 21.49 crore shares of Sun Pharma.

Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.